Intrinsic Tumour Factors Affecting Recurrence in Non Muscle Invasive Bladder Cancer: a Hospital Based Study from India |
Mehta, Nisarg
(Department of Urology, Lourdes Hospital)
Rathore, Ranjeet Singh (Department of Urology, Lourdes Hospital) Pillai, Biju S (Department of Urology, Lourdes Hospital) Sam, Mohan P (Department of Urology, Lourdes Hospital) Moorthy, Krishna (Consultant, Lourdes Hospital) |
1 | Ali-El-Dein B, Sarhan O, Hinev A, et al (2003). Superficial bladder tumours: Analysis of prognostic factors and construction of a predictive index. BJU Int, 92, 393-9. DOI |
2 | Badar F, Sattar A, Meerza F, Irfan N, Siddiqui N (2009). Carcinoma of the urinary bladder in a tertiary care setting in a developing country. Asian Pac J Cancer Prev, 10, 449-2 |
3 | Brausi M, Collette L, Kurth K, et al (2002). EORTC Genito-Urinary Tract Cancer Collaborative Group: Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta\T1 transitional Cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol, 41, 523-1. DOI |
4 | Ghafouri-Fard S, Nekoohesh L, Motevaseli E (2014). Bladder cancer biomarkers: review and update. Asian Pac J Cancer Prev, 15, 2395-3. DOI |
5 | Hall CM, Chang SS, Dalbagni G, et al (2007). Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 Update from the American Urological Association Education and Research, Inc J Urol, 178, 2314-0 DOI |
6 | Heney NM, Nocks BN, Daly JJ, et al (1982). Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol, 52, 152-7 |
7 | Herr HW (2000). Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol, 163, 60-1 DOI |
8 | Jemal A, Bray F, Center MM, et al. Global cancer statistics (2011). CA Cancer J Clin, 61, 69-0. DOI |
9 | Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer (2000). J Urol, 163, 73-8. DOI |
10 | Oosterlinck W. Guidelines on diagnosis and treatment of superficial bladder cancer (2004). Minerva Urol Nephrol, 56, 65-2. |
11 | Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006). Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol, 3, 327-0. DOI |
12 | Sylvester RJ, Van der Meijden AP, Oosterlinck W, et al (2006). Predicting recurrence and progression in individual patients with stage Ta, T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol, 3, 466-5. |
13 | Salehi A, Khezri A, Malekmakan L, Aminsharifi A (2011). Epidemiologic status of bladder cancer in Shiraz, Southern Iran. Asian Pac J Cancer Prev, 12, 1323-7. |
14 | Shakhssalim N, Hosseini SY, Basiri A, et al (2010). Prominent bladder cancer risk factors in Iran. Asian Pacific J Cancer Prev, 11, 601-6. |
15 | Supit W, Mochtar CA, Sugiono M, Umbas R (2011). Survival of patients with transitional cell carcinoma of the urinary bladder in Indonesia: A single institution review. Asian Pac J Cancer Prev, 12, 549-3 |
16 | Wu X, Ros MM, Gu J, Kiemeney L (2008). Epidemiology and genetic susceptibility to bladder cancer. BJU Int, 102, 1207-5. DOI |
17 | Yaris F, Dikici MF, Sabuncu HH, Yaris E (2006). A case-control study on the etiology of urinary bladder cancer in Istanbul, Turkey. Asian Pac J Cancer Prev, 7, 591-4. |
18 | Yavari P, Sadrolhefazi B, Mohagheghi MA, Mehrazin R (2009). A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003). Asian Pac J Cancer Prev, 10, 681-4. |
19 | Zeegers MP, Tan FE, Dorant E, van der Brandt PA (2000). The impact of characteristics of cigarette smoking on urinary tract cancer risk: A meta-analysis of epidemiologic studies. Cancer, 89, 630-9. DOI |